Mehran Feizi‐Dehnayebi
Mehran Feizi‐Dehnayebi publishes mostly in Organic Chemistry, Oncology and Materials Chemistry, on topics such as Metal complexes synthesis and properties, Synthesis and biological activity and Molecular Sensors and Ion Detection.
- World rank
- #14,325 of 7,710,434 ranked researchers
- Rank in Iran
- #58 of 71,317
- Works
- 92
- Citations
- 3.1k
- Citations per work
- 33.3
What does Mehran Feizi‐Dehnayebi research?
Mehran Feizi‐Dehnayebi's work is mostly in Chemistry (42%), Medicine (12%), Materials Science (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences4952.8%
- Chemistry3942.0%
- Materials Science1010.8%
- Everything else2425.6%
- Health Sciences1111.6%
- Medicine1111.6%
- Life Sciences910.0%
- 1Organic Chemistry29% of their works
- 2Oncology12% of their works
- 3Materials Chemistry11% of their works
- 4Molecular Biology10% of their works
- 5Spectroscopy7% of their works
- 6Inorganic Chemistry6% of their works
Research topics
- Metal complexes synthesis and properties
- Synthesis and biological activity
- Molecular Sensors and Ion Detection
- Synthesis and Characterization of Heterocyclic Compounds
- Computational Drug Discovery Methods
- Synthesis and Biological Evaluation
- Analytical Chemistry and Sensors
- Metal-Organic Frameworks: Synthesis and Applications
Which keywords describe Mehran Feizi‐Dehnayebi's research?
The keywords of their largest research topics: Anticancer Agents, Medicinal Chemistry, Heterocyclic Compounds, Cisplatin Resistance, Platinum-Based Drugs, Tubulin Inhibitors, Vascular Targeting Agents and Molecular Docking.
- Porous Materials
- Metal-Organic Frameworks
- Quinoxaline
- Virtual Screening
- Triazines
- Ion Detection
- Synthesis
- Molecular Docking
- Tubulin Inhibitors
- Cisplatin Resistance
- Medicinal Chemistry
- Anticancer Agents
- Heterocyclic Compounds
- Platinum-Based Drugs
- Vascular Targeting Agents
- Biological Evaluation
- Fluorescent Chemosensors
- Antimicrobial
- Drug Target Identification
- Antimicrobial Activity
- Ion-Selective Electrodes
- Optical Sensors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Anticancer Agents583 topics
- Medicinal Chemistry403 topics
- Heterocyclic Compounds302 topics
- Cisplatin Resistance281 topic
- Platinum-Based Drugs281 topic
- Tubulin Inhibitors221 topic
- Vascular Targeting Agents221 topic
- Molecular Docking212 topics
- Biological Evaluation192 topics
- Synthesis192 topics
- Fluorescent Chemosensors171 topic
- Ion Detection171 topic
- Antimicrobial111 topic
- Triazines111 topic
- Drug Target Identification101 topic
- Virtual Screening101 topic
- Antimicrobial Activity81 topic
- Quinoxaline81 topic
- Ion-Selective Electrodes71 topic
- Metal-Organic Frameworks71 topic
- Optical Sensors71 topic
- Porous Materials71 topic
Where does Mehran Feizi‐Dehnayebi work?
Mehran Feizi‐Dehnayebi's main affiliation in the publication record is Alzahra University, Iran.
How many publications and citations does Mehran Feizi‐Dehnayebi have?
OpenAlex counts 92 works and 3,067 citations for Mehran Feizi‐Dehnayebi, an h-index of 38, ranking #14,325 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mehran Feizi‐Dehnayebi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.